Zobrazeno 1 - 10
of 22
pro vyhledávání: '"J. F. Lucía"'
Autor:
M. Dobon, J. F. Lucía, R. Cornudella, M. T. Calvo, E. Tizano, C. Aguilar, C. Borés, J. A. Aznar
Publikováno v:
Haemophilia. 11:561-564
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3525be6a666ca31458d744e9202cf176
https://doi.org/10.1111/j.1365-2516.2005.01122.x
https://doi.org/10.1111/j.1365-2516.2005.01122.x
Autor:
A. Ferrández, E. Mayayo, M. Giralt, V. Solano, M. Roca, M. Dobon, C. Aguilar, J. F. Lucía, Adolfo Peña
Publikováno v:
Haemophilia. 9:76-85
An orthopaedic assessment of the joint status of seven severe haemophiliacs (mean age 12.5 y - range 8.9-15.5) on prophylactic treatment (PT) by magnetic resonance imaging (MRI) and physical examination was carried out. Median duration of PT of these
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b805a56b1735d1199df25c57579a5565
https://doi.org/10.1046/j.1365-2516.2003.00702.x
https://doi.org/10.1046/j.1365-2516.2003.00702.x
Publikováno v:
Haemophilia. 7:600-602
Recombinant factor VIIa (rfVIIa) has been widely used for the treatment and prevention of bleeding episodes in haemophiliacs with high-titre inhibitors. High single doses are the treatment of choice for joint and muscle bleeds in those patients. Ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::971602f4d19d217a2e92f2f52712a787
https://doi.org/10.1046/j.1365-2516.2001.00568.x
https://doi.org/10.1046/j.1365-2516.2001.00568.x
Publikováno v:
Haemophilia. 7:6-8
The combination of interferon (IFN) and ribavirin is the current gold standard for treatment of chronic hepatitis C virus (HCV) infection with sustained remission rates of 35--40% being achieved in haemophilic patients. A similar beneficial effect of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a5814284cb0b46b3fb37b91b6593dbd
https://doi.org/10.1046/j.1365-2516.2001.00462.x
https://doi.org/10.1046/j.1365-2516.2001.00462.x
Publikováno v:
Haemophilia. 7:6-8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1951f392de7830f20568796c25ac7c59
https://doi.org/10.1111/j.1365-2516.2001.00462.x
https://doi.org/10.1111/j.1365-2516.2001.00462.x
Autor:
J F, Lucía, J A, Aznar, L, Abad-Franch, R R, Escuin, V, Jiménez-Yuste, R, Pérez, J, Batlle, I, Balda, G, Alperovich, R, Parra, E, Navarro
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 17(1)
The Spanish Epidemiological Study in Haemophilia carried out in 2006 enrolled 2400 patients [2081-86.7% with haemophilia A (HA) and 319-13.3% with haemophilia B]; 465 of them (19.4%) were on prophylaxis. These rates were higher in patients with sever
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3a716e324f3b4625189dcdbe573db67d
https://pubmed.ncbi.nlm.nih.gov/21070481
https://pubmed.ncbi.nlm.nih.gov/21070481
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 9(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e3f45d52a3d30894a504663c91f6bc4
https://pubmed.ncbi.nlm.nih.gov/12558789
https://pubmed.ncbi.nlm.nih.gov/12558789
Autor:
M, Dobón, J F, Lucía, C, Aguilar, E, Mayayo, M, Roca, V, Solano, A, Peña, M, Giralt, A, Ferrández
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 9(1)
An orthopaedic assessment of the joint status of seven severe haemophiliacs (mean age 12.5 y - range 8.9-15.5) on prophylactic treatment (PT) by magnetic resonance imaging (MRI) and physical examination was carried out. Median duration of PT of these
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a788b5f94045fa7fa726dda3501ff548
https://pubmed.ncbi.nlm.nih.gov/12558783
https://pubmed.ncbi.nlm.nih.gov/12558783
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 7(6)
Recombinant factor VIIa (rfVIIa) has been widely used for the treatment and prevention of bleeding episodes in haemophiliacs with high-titre inhibitors. High single doses are the treatment of choice for joint and muscle bleeds in those patients. Ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c7c5cd84fc51000fd7b215ab87c31cd0
https://pubmed.ncbi.nlm.nih.gov/11851761
https://pubmed.ncbi.nlm.nih.gov/11851761
Publikováno v:
Haemophilia. 13:224-225
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::786e7d254d4c90d8b2e6b8981cc253ac
https://doi.org/10.1111/j.1365-2516.2006.01434.x
https://doi.org/10.1111/j.1365-2516.2006.01434.x